from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3776/-

LFCtreatmentdescriptionclass of inhibitor

-0.816

Amikacinug/mL Amikacintranslation

-1.638

Cap5-10ug/mL Capreomycintranslation

-0.858

Rox10-50 ug/mL Roxithromycintranslation

-0.755

SM2-5 ug/mL Streptomycintranslation

-1.490

Tet5-10 ug/mL Tetracyclinetranslation

0.556

Rif0.2-5ug/mL Rifampicintranscription

-0.095

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.086

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.817

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.153

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.869

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.603

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.729

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.628

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.049

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.784

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.034

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.221

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.471

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.125

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.518

KCN5-20 ug/mL Potassium cyaniderespiration

-0.470

NaN30.2-2 mM Sodium aziderespiration

-0.885

Nigericin50 uM Nigericinrespiration

0.920

TRC10-150 ug/mL Triclosanrespiration

0.223

TRZ10-25 ug/mL Thioridazinerespiration

-0.663

Valinomycin0.5-10 uM Valinomycinrespiration

-1.811

ZnSO42 mM ZnSO4respiration

-0.851

menadione6-10 ug/mL Menadionerespiration

-0.492

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.590

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.446

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.894

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.414

NRP_1Non-replicating persistence stage 1dosRassociated

-0.244

Amp0.2mg/mL AmpicillincellWall

-0.270

Cephalexin20-100 ug/mL CephalexincellWall

-0.339

Cerulenin0.32-5 ug/mL CerulenincellWall

0.397

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.450

EMB10-20 ug/mL EthambutolcellWall

-1.052

Eta12-40 ug/mL EthionamidecellWall

-0.841

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.433

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.415

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.484

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.046

BZA0.12 mg/mL BenzamidearomaticAmides

0.547

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.204

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.497

H2O24 mM hydrogen peroxideDNAdamaging

2.083

Levo10 ug/mL LevofloxacinDNAdamaging

0.644

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.308

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.879

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.450

UVUV-irradiationDNAdamaging

-0.042

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.515

Antimycin12.5-50 ug/mL Antimycin A?

-1.073

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.370

PA_110-50 ug/mL Antitubercular compound PA-1?

0.293

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.231

PA8240.2-2 ug/mL PA-824?

0.364

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.179

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.971

Verapamil50 uM Verapamil?

-0.972

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.059

methoxatin10-20 ug/mL Methoxatin?